Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab and RAD001 in Trastuzumab-Resistant Metastatic Breast Cancer
NCT00317720Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2006
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2006; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00317720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317720.